Bitten Schönewolf-Greulich

Bitten Schönewolf-Greulich

Auto-generated profile, based on publicly available information

Bitten Schönewolf-Greulich

Department of Clinical Genetics, Kennedy Center Copenhagen University Hospital, Rigshospitalet Glostrup Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2019 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
TSTristan T. Sands
Tristan T. Sands
FMFrancesco Miceli
Francesco Miceli
GLGaetan Lesca
Gaetan Lesca
ABAnita E. Beck
Anita E. Beck
LSLynette G. Sadleir
Lynette G. Sadleir
MCM. Roberta Cilio
M. Roberta Cilio

28 October 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
LHLijia Huang
Lijia Huang
MVMegan R. Vanstone
Megan R. Vanstone
THTaila Hartley
Taila Hartley
MOMatthew Osmond
Matthew Osmond
NBNick Barrowman
Nick Barrowman
MLMatthew A. Lines
Matthew A. Lines

23 February 2019 in Journal of Neuromuscular Diseases
Verified
Journal Article
Closed access
PDF file
DWDineke Westra
Dineke Westra
MSMeyke I. Schouten
Meyke I. Schouten
BSBas C. Stunnenberg
Bas C. Stunnenberg
BKBenno Kusters
Benno Kusters
CSChristiaan G.J. Saris
Christiaan G.J. Saris
NVNicol Voermans
Nicol Voermans
Background: Neuromuscular disorders (NMDs) are clinically and genetically heterogeneous. Accurate molecular genetic diagnosis can improve clinical management, provides appropriate genetic counseling and testing of relatives, and allows potential therapeutic trials. Objective: To establish the clinical utility of panel-based whole exome sequencing (WES) in NMDs in a population with children and adults with various neuromuscular symptoms. Methods: Clinical exome sequencing, followed by diagnostic interpretation of variants in genes associated with NMDs, was performed in a cohort of 396 patients suspected of having a genetic cause with a variable age of onset, neuromuscular phenotype, and inheritance pattern. Many had previously undergone targeted gene testing without results. Results: Disease-causing variants were identified in 75/396 patients (19%), with variants in the three COL6-genes ( COL6A1, COL6A2 and COL6A3) as the most common cause of the identified muscle disorder, followed by variants in the RYR1 gene. Together, these four genes account for almost 25% of cases in whom a definite genetic cause was identified. Furthermore, likely pathogenic variants and/or variants of uncertain significance were identified in 95 of the patients (24%), in whom functional and/or segregation analysis should be used to confirm or reject the pathogenicity. In 18% of the cases with a disease-causing variant of which we received additional clinical information, we identified a genetic cause in genes of which the associated phenotypes did not match that of the patients. Hence, the advantage of panel-based WES is its unbiased approach. Conclusion: Whole exome sequencing, followed by filtering for NMD genes, offers an unbiased approach for the genetic diagnostics of NMD patients. This approach could be used as a first-tier test in neuromuscular disorders with a high suspicion of a genetic cause. With uncertain results, functional testing and segregation analysis are needed to complete the evidence.

11 July 2020 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SKSimranpreet Kaur
Simranpreet Kaur
NBNicole J Van Bergen
Nicole J Van Bergen
KVKristen J. Verhey
Kristen J. Verhey
CNCameron Nowell
Cameron Nowell
BBBreane Budaitis
Breane Budaitis
JCJohn Christodoulou
John Christodoulou

20 August 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MNMiriam Nøstvik
Miriam Nøstvik
SKSarah M. Kateta
Sarah M. Kateta
BSBitten Schönewolf‐Greulich
Bitten Schönewolf‐Greulich
AAAlexandra Afenjar
Alexandra Afenjar
MBMagalie Barth
Magalie Barth
Zeynep TümerZeynep Tümer
Zeynep Tümer

25 January 2018 in Clinical Genetics
Verified
Journal Article
Closed access
BSB. Schönewolf‐Greulich
B. Schönewolf‐Greulich
ABA‐M. Bisgaard
A‐M. Bisgaard
RMR.S. Møller
R.S. Møller
MDM. Dunø
M. Dunø
KBK. Brøndum‐Nielsen
K. Brøndum‐Nielsen
Zeynep TümerZeynep Tümer
Zeynep Tümer